Alex Biese

CURE® spoke with a physical therapist specializing in oncology to find out more about this condition some patients with cancer are at risk for.

Researchers have found an overall survival benefit and manageable safety profile with Venclexta for patients with AML and MDS.

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients with cancer to enroll.

An expert explained how circulating tumor cell count can identify possible clinical trial participants.

From producer Quincy Jones’ death from pancreatic cancer to an inspiring moment between The Rock and a fan at a store, here’s what’s happening in the cancer space this week.

Immune checkpoint inhibitor tumor regression may indicate which patients with hepatocellular carcinoma experience improved relapse-free survival.

An expert explains how attitudes towards lymphedema risk have evolved over the years.

The actor, 65, received his diagnosis of stage 3 non-Hodgkin lymphoma in October, he said.

Three cycles of chemotherapy were found to face similar results as six cycles among children with retinoblastoma, a type of cancer of the eye.

Researchers have found an association between baseline circulating tumor cell count and survival in metastatic hormone-sensitive prostate cancer.

Rates of colorectal cancer diagnoses and deaths are climbing among patients younger than 55, researchers have shown.

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial.

Among patients with polycythemia vera, the treatment pairing of Jakafi and Pegasys shows benefits with acceptable toxicity, research showed.

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

From World Series tickets given to a pediatric patient with cancer to the death of David Harris, known as Cochise in “The Warriors,” at the age of 75, here is this week’s cancer news.

Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.

The agency is alerting patients and providers to not use the implantable devices, made for soft tissue such as breast tissue.

A phase 2 clinical trial of a new brain cancer treatment is underway.

An expert answers prostate cancer questions from a recent CURE Educated Patient Summit.

An expert told CURE that patients with cancer should discuss palliative care options with their team “as early as possible.”

The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year.

Researchers have found that engaging in aerobic physical activity results in modest depression reduction among some patients with cancer.

From “The Office” star opening up in a new interview to Charley Steiner revealing his multiple myeloma journey, here is this week’s cancer news.

Adjusted survival outcomes were similar for patients with NPM1-mutated AML with intensive induction chemotherapy or hypomethylating agents and Venclexta.

Often mistaken as a synonym for hospice care, palliative care can be critical for patients with cancer and serious illnesses.

Results from the RAMP 201 clinical trial are promising for patients with recurrent low-grade serous ovarian cancer.

For patients with cancer, Symproic may prevent constipation and improve quality of life.

The FDA has approved Vyloy for patients with HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma with CLDN18.2-positive tumors.